Further investigations are required to confirm whether elevated circulating levels of IL-13, TGF-β1, and periostin were associated with cardiovascular events and in-hospital deaths, thus estimating their prognostic values for patients with CAD and HF. This evidence concerns the gene IL13 and coronary artery disorder.